Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 871275 | ISIN: US2394671034 | Ticker-Symbol: DX5
Frankfurt
28.03.24
16:51 Uhr
7,650 Euro
-0,100
-1,29 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DAXOR CORPORATION Chart 1 Jahr
5-Tage-Chart
DAXOR CORPORATION 5-Tage-Chart

Aktuelle News zur DAXOR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoDaxor Corporation (DXR) Q4 2023 Earnings Call Transcript1
MoDAXOR CORP - 8-K, Current Report1
MoDaxor acquires Volumex and Megatope from existing supplier1
MoDaxor Corporation Acquires Volumex and Megatope From Its Existing Supplier Along With Glofil to Enhance Existing Suite of Diagnostics93Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology...
► Artikel lesen
22.03.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 20241
18.03.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 202320Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in...
► Artikel lesen
18.03.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders31Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders...
► Artikel lesen
11.03.Daxor Corporation: Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base2
08.03.Daxor Corporation: Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients2
26.02.Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference1
12.02.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions181Oak Ridge, TN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces two significant new customer transactions...
► Artikel lesen
02.01.DAXOR CORP - 8-K, Current Report-
02.01.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer228The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
► Artikel lesen
28.11.23DAXOR CORP - 8-K, Current Report-
13.11.23Daxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure Patients238Data From Study Funded by NIH Presented at the American Heart Association Annual Meeting Oak Ridge, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
► Artikel lesen
27.10.23DAXOR CORP - 8-K, Current Report1
13.10.23Daxor Corporation: Expert Panelists Advocate Use of Daxor's Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting1
11.10.23Daxor Corporation: New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting1
28.08.23Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders414Oak Ridge, TN, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to Shareholders...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1